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Adaptive mechanisms involving upregulation of cytoprotective genes under the control of transcription
factors such as Nrf2 exist to protect cells from permanent damage and dysfunction under stress conditions.
Here we explore of the hypothesis that Nrf2 activation by reactive oxygen and nitrogen species modulates
cytotoxicity during hypoxia (H) with and without reoxygenation (H/R) in H9C2 cardiomyoblasts. Using
MnTBap as a cell permeable superoxide dismutase (SOD) mimetic and peroxynitrite scavenger and L-NAME
as an inhibitor of nitric oxide synthase (NOS), we have shown that MnTBap inhibited the cytotoxic effects of
hypoxic stress with and without reoxygenation. However, L-NAME only afforded protection during H. Under
reoxygenation, conditions, cytotoxicity was increased by the presence of L-NAME. Nrf2 activation was
inhibited independently by MnTBap and L-NAME under H and H/R. The increased cytotoxicity and inhibition
of Nrf2 activation by the presence of L-NAME during reoxygenation suggests that NOS activity plays an
important role in cell survival at least in part via Nrf2-independent pathways. In contrast, O2 scavenging
by MnTBap prevented both toxicity and Nrf2 activation during H and H/R implying that toxicity is largely
dependent on O2
d.To conﬁrm the importance of Nrf2 for myoblast metabolism, Nrf2 knockdown with
siRNA reduced cell survival by 50% during 4 h hypoxia with and without 2 h of reoxygenation and although
cellular glutathione (GSH) was depleted during H and H/R, GSH loss was not exacerbated by Nrf2
knockdown. These data support distinctive roles for ROS and RNS during H and H/R for Nrf2 induction
which are important for survival independently of GSH salvage.
& 2013 The Authors. Published by Elsevier B.V.
Introduction
Oxygen insufﬁciency, hypoxia, may arise in tissues during
physiological and pathophysiological conditions such as exercise
or a reduction in blood ﬂow during ischemia. Adaptive mechan-
isms exist to protect cells from permanent damage and dysfunc-
tion due to hypoxia [1,2]. Effective sensing of oxygen availability
allows cells to activate speciﬁc adaptive responses during hypoxia
that confer protection [3]. Many of these responses are controlled
by hypoxia-inducible factors (HIFs) whose activity is regulated by
oxygen via HIF-prolyl hydroxylase and which mediate the expres-
sion of molecules such as haem oxygenase-1 and ferritin [4–6].
When the oxygen supply is inadequate, cellular respiration shifts
from aerobic fatty acid metabolism to anaerobic glycolysis thereby
sustaining ATP production, albeit at a lower level [7,8].
Reactive oxygen (ROS) and/or nitrogen (RNS) species have been
strongly implicated in ischaemic or hypoxic-toxicity, with and without
reperfusion although there is a lack of agreement over their respective
mechanisms of action [9–12]. There are a number of transcription
factors whose activation is regulated either directly or indirectly by
ROS/RNS; For example, ROS/RNS can act as potent electrophiles and
key activators of nuclear factor erythroid 2-related factor 2 (Nrf2)
[13,14]; a master regulator of the speciﬁc antioxidant phenotype
[15,16]. During normoxia, Nrf2 is held in the cytoplasm and main-
tained at low levels by a cytoskeletal-associated inhibitory protein;
Kelch-like ECH-associated protein 1 (KEAP1), which promotes rapid
degradation of Nrf2 via KEAP1-dependent ubiquitin conjugation [13].
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During oxidative stress, thiol oxidation occurs in the hinge region of
KEAP1, resulting in a conformational change in KEAP1 with the loss of
Nrf2 binding [17]. Then Nrf2 accumulates, undergoes modiﬁcation by
phosphorylation mediated by PKCδ and Akt and is translocated to the
nucleus e.g. in epithelial cells [18]. cAMP-responsive element-binding
protein (CREB)-dependent acetylation of Nrf2 promotes its binding to
DNA [18]. With its cofactors, nuclear Nrf2 up-regulates cytoprotective
genes through the transcriptional activation of genes binding to a cis-
acting enhancer sequence of upstream of the antioxidant response
element (ARE) [19]. Nrf2 is essential for transcriptional activation of
several genes including gamma glutamyl cysteinyl ligase the rate
limiting enzyme in glutathione synthesis and the subunits of the
proteasome responsible for degradation of oxidatively damage pro-
teins [20,21].
A change in expression and activation of Nrf2 has profound effects
on the physiological response to oxygen insufﬁciency; for example,
infarcted volume is reduced following focal cerebral ischaemia in the
presence of the Nrf2 inducer, sulforaphane [22]. Moreover, Lee et al.
[23] showed that neural cells lacking in Nrf2 (Nrf2/ mice) were
more susceptible to oxidative stress than control neurons from wild-
type mice (Nrf2 þ/þ wild mice). However, when the cells derived
from Nrf2/ mice were transfected with a functional Nrf2
construct, they became resistant to oxidative stress. Dhakshina-
moorthy and Porter, reported that dominant negative-Nrf2 stable
neuroblastoma cells were more prone to apoptosis induced by nitric
oxide when they were Nrf2 silenced with siRNA [24] compared to
Nrf2 expressing cells. This mechanistic controversy over ROS/RNS
functions limits their potential as targets for addressing H and H/R
toxicity. Therefore, we have developed a simple model to deﬁne the
role for Nrf2, its induction via NOS and O2d dependent pathways
and effect in protecting cardiomyoblasts during H and H/R.
Experimental
Routine cell culture
ATCC H9C2 (1-2) rat-cardiomyoblasts were maintained routinely
in Dulbecco′s modiﬁed Eagle′s medium (DMEM) up to passage 20
and supplemented with heat inactivated 10% fetal bovine serum
(FBS), 4 mM L-glutamine and 200 U/ml penicillin and 200 mg/ml
streptomycin at 37 1C in a humidiﬁed atmosphere of 5% CO2 and
95% air.
Induction of hypoxia (H) or hypoxia/reoxygenation (H/R)
Cells were maintained in preincubated hypoxic or normoxic
phenol red-free DMEM which was supplemented with 25 mM
HEPES (4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid),
with penicillin/streptomycin as above (complete media). Estimates
of O2 tension in tissue vary between 10 and 14% O2 and will
ﬂuctuate during physiological stress and pathophysiological con-
ditions which reduce O2 delivery to tissues [25]. In normal
myocardial perfusion in rat hearts, mean PO2 values were reported
as 240 7140 Torr and during local ischemia, the mean PO2
changed to 50790 Torr which is equivalent to 6.7% oxygen [26].
For hypoxia or normoxia experiments, the medium was preincu-
bated for 24 h in a hypoxic environment (2% O2þ98% N2) and 10%
O2þ90% N2 and 21% O2þ79% N2 for control experiments (BOC,
UK). pH stability was assessed as described previously [27,28].
The experimental design is shown in Fig. 1.
Measurement of superoxide/RNS generation during hypoxia (H) and
hypoxia/reoxygenation (H/R)
For analysis of ROS and RNS, plates were sealed at 3 min prior
to the end of each experiment and centrifuged at 400g for 3 min.
For H/R, supernatants were gently removed and replaced with pre-
equilibrated reoxygenated medium (21% O2þ79% N2) and incu-
bated further for 2 h reoxygenation. 45 min before completing
each experiment ﬂuorescent probe (20 mM DHE or 100 mM DAF-2-
DA) was added into wells without incorporating air. The plate was
then returned to the pre-equilibrated chamber and ﬂushed with
premixed normoxic gas at a higher ﬂow rate (2000 ml/min) for
3 min to stabilize the experimental conditions. This was calculated
in the basis of the volume of the incubating chamber and allowed
for 10 exchanges of air. Fluorescence was determined at 37 1C in a
preheated ﬂuorescence reader (Molecular Devices). Cells were
2% or 21% O2 pre-equilibrated medium added to cells           viability, GSH and luciferase analysis
Pre-equilibration of media (24h)                                                                                     (-) old medium  
2% or 21% O2 3min                            3h 57min                                   2h
(+) 
Medium Cells (+) pre-equilibrated fresh medium at either
Gas flow rate 25ml/min                                                       21% (reoxygenation)
Gas flow rate 2L/min or 2% (hypoxia)
Gas flow rate 25ml/min
2% or 21% O2
Hypoxia (H) 4h 2% O2 or 10% O2
Hypoxia/reperfusion (H/R) 4h + 2h
Sustained hypoxia (S-H) 4h + 2h
2% O2 + 21% O2
2% O2 + 2% O2
Fig. 1. Schematic plan of experimental hypoxia and reoxygenation experiment. Media was pre-equilibrated at desired oxygen tension for 24 h prior to each experiment. At
the start of each experiment, pre-equilibrated media was added to near conﬂuent cells and the incubator was ﬂushed with appropriate oxygen tension at a high ﬂow rate for
3 min, then ﬂow rate was returned to 25 ml/min for the remainder of the study period. After 4 h, for H/R experiments, 2% oxygen media was removed and pre-equilibrated
21% oxygen media added with 21% oxygen ﬂushed into the incubator for the remaining 2 h. Cells that were to be retained in the same oxygen tension (either sustained
hypoxia or normoxia) also underwent a change in media at the same time points but oxygen tension remained unchanged.
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then lysed using 2% triton. Fluorescence in each well was calcu-
lated in arbitrary ﬂuorescent units per 1 mg of total protein. Live
imaging was achieved with a Carl Zeiss LSM 700 confocal micro-
scope (Germany). The 488 nm argon laser line was used to excite
DHE, which was measured by ﬂuorescence emission using a band
pass ﬁlter from 570 to 590 nm, with DAF-2-DA ﬂuorescent probe
monitored at Ex: 480–490 nm and Em: 510–520 nm. Illumination
intensity was set up at a minimum (0.1–0.2% of laser output) to
avoid photo-oxidation and the pinhole set to give the optical beam
at 2 nm for optimum resolution. Each experiment was undertaken
using by at least 3 independent chamber wells.
Cytotoxicity assays
Cell viability was assessed as the ratio of excluded propidium
iodide (DNA staining due to permeable membrane) to Hoechst
33342 (DNA staining in all cells) and as caspase 3 cleavage by
western blotting as described previously [28]. MTT assay was also
employed to assess the loss of metabolic activity during hypoxia
(H), sustained hypoxia (S-H) or hypoxia/reoxygenation (H/R). Cells
were seeded at a density of 3104 cells/well until they reached
80–90% conﬂuence. 2 h prior to completion of S-H or H/R,
dimethyl thiazolyl diphenyl tetrazolium salt (MTT) solution
(100 ml of 5 mg/ml in 0.01 M PBS) was added to all wells. Control
cells under normoxia also received the MTT solution prior to 1 h or
2 h as appropriate to the experimental set up. After completing
hypoxia or reoxygenation, lysis buffer (100 ml, 20% w/v SDS in 50%
DMF, dH2O (50%), pH 4.7 adjusted with 2.5% of glacial acetic acid)
was added to each well and incubated for a further 16 h at 37 1C in
a humidiﬁed atmosphere of 5% CO2 and 95% air [29] and then
formazan production was assessed at 570 nm. Loss of metabolic
activity was calculated by comparing results to normoxic cells
which were considered as 100% metabolically active.
Transient transfection of plasmid DNA into H9C2 cardiomyoblasts
The luciferase reporter plasmid vector pGL 3 [nqo1/luc] was
generated using the pGL3-promoter vector (Promega,UK) contain-
ing an ARE consensus sequence from the upstream of nqo1
promoter and the ﬁreﬂy luciferase reporter gene (luc), The
pGL4.74[hRluc/TK] plasmid vector containing the thymidine kinase
(TK) promoter upstream of hRluc for Renilla luciferase expression
was employed as an internal control in co-transfected H9C2
cardiomyoblasts.
Expression of Renilla luciferase (Rluc) upon the activation of TK
promoter in the pGL4.74 [TK/hRluc] plasmid provides an internal
control value to which expression of the experimental luc gene with
nqo1 promoter was normalized in the subsequent reporter gene assay
[30]. Lipofectamine 2000 was diluted and gently mixed with 50 ml of
Opti-MEM I reduced serum medium and incubated for 25 min [29].
After 25 min incubation, the diluted DNA samples (1:10) were
combined with diluted Lipofectamine 2000 and incubated for a
further 25 min at room temperature. 100 ml of DNA and Lipofectamine
2000 complex was then added to each well with 400 ml of medium
and the content was gently mixed. After 6 h of transfection, 500 ml of
culture medium containing 20% FBS and 8mM L-glutamine was added
to all transfected and non-transfected cell wells.
Luciferase reporter gene assay
To measure the luciferase reporter activity in transfected cells
after exposure to hypoxia, a Dual Glo luciferase assay (Promega,
UK) was performed according to the manufacturer′s protocol.
Plates were centrifuged at 300g for 3 min to collect dead cells
due to hypoxia treatment.
The ratio of luminescence of experimental reporter to control
reporter was normalised to account for any cell loss. Hydrogen
peroxide (100 mM) was employed over 6 h to activate transcription
factors as a positive control.
Nrf2-RNA interference assay
Transient transfection with Nrf2-siRNA was performed using
Lipofectamine RNAimax reagent according to a modiﬁed protocol
and manufacturer′s instructions. H9C2 cells at approximately 50 to
70% conﬂuence were transfected with siNrf2 or scrambled Nrf2-
siRNA (scr/siRNA) (Invitrogen, UK). Cell culture medium was
replaced at 6 h after transfection, and cells were then further
incubated for 16–24 h before expose to hypoxia and/or reoxygena-
tion or S-H. The knockdown efﬁciency was validated by western
blotting [25].
Cellular glutathione
After 6 h incubation, cells were scraped from the plate and
washed twice with PBS and sulfosalicylic acid (SSA; 3.33 ml of 100%
made up in distilled water) was then added to the cell pellet.
Following centrifugation at 6600g for 1.5 min, stock buffer (96.6 ml
of 125 mM sodium phosphate, 6.3 mM disodium EDTA, pH 7.5)
was then added to each tube and supernatants were collected
carefully and stored immediately at 80 1C 80 1C prior to analysis
of GSH by the GSR-DTNB (5,5'-dithiobis-(2-nitrobenzoic acid))
recycling assay within one month [27].
Statistical analysis
Results are presented as sample mean7SEM. Statistical analy-
sis was performed using Graphpad Prism software (version 5) and
tested by one-way ANOVA (nonparametric) using Tukey′s post-
hoc test. All results are means of three independent experiments
and Po (0.05)n was considered as signiﬁcantly different from
controls.
Results
Initial studies were performed to determine the stability of the
hypoxic chamber system. The dissolved O2 concentration in
control medium (normoxia) was measured as 5.9370.23 mg/l.
After 24 h, the dissolved O2 concentration in the medium under 2%
O2 was decreased by 26-fold (2%O2 0.2370.04 mg/l) and at 10% O2
decreased by 3-fold (2.7870.77 mg/l). Conversely, the pH of the
medium was stable over a 24 h period during both normoxia (21%
O2; pH 7.470.30), hypoxia (2%O2 pH 7.570.21) and at 10%O2 (pH
7.570.23).
The effect of oxygen tension on metabolic activity and viability of
cardiomyoblasts
The overproduction of ROS/RNS during H and H/R may arise
from and/or lead to mitochondrial dysfunction with associated cell
death [9]. To test this hypothesis, we determined H and H/R-
induced cell death and metabolic change by Hoechst and PI
staining, caspase blots and MTT activity assays.
Analysis of necrotic death was undertaken by co-staining with
Hoechst and PI. PI uptake was signiﬁcant during 4 h H (2% O2
Po0.05) but not at 10% O2 compared to normoxia (Fig. 2A). After
incubation at 2%, 10% and 21%O2 for 4 h, total cell lysates (20 mg)
were resolved by SDS-PAGE and transferred to PVDF membranes
for immunoblotting for procaspase 3 and cleaved caspase 3. The
larger cleaved fragment (18 kDa) of procaspase-3 was detected in
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cardiomyoblasts exposed to 2% and 10% O2 for 4 h (Fig. 2B and C).
However, no cleavage band was detected under normoxia con-
ﬁrming that apoptosis is increased by H only.
Hypoxia (2%O2 4 h) caused more than 20% loss in metabolic
activity (Po0.001; Fig. 2D and E) whereas H/R (2%O2 4 hþ21%O2
2 h), caused a 15% loss in metabolic activity compared to normoxia
(21%O2 6 h)-maintained controls (Po0.001; Fig. 2E). These data
show that the severity of H associates with metabolic inhibition but
that the metabolic effects of H/R are less than those of S-H alone.
Hypoxia/reoxygenation induced O2
d generation and increased dNO
production
To investigate whether H/R may increase O2d production more
than H alone in cardiomyoblasts, O2d production was measured
using DHE oxidation and inhibition by MnTBap. The speciﬁcity of
DHE for discrete ROS such as the superoxide anion radical is
dependent on the analytical method employed with HPLC analysis
being the most speciﬁc method and although less-speciﬁc spectro-
photometric analysis has been used here, this approach in combi-
nation with superoxide scavenging e.g. by SOD or the mimetic
MnTBap, can infer O2d involvement in a biological process. As
shown in Fig. 3A and C, DHE ﬂuorescence was signiﬁcantly
increased after 2 h of reoxygenation compared to hypoxic and
normoxic controls and this was inhibitable by MnTBap, suggesting
a signiﬁcant increase in O2d production during the reoxygenation
period alone after S-H (Po0.001). The ﬁndings of DHE oxidation
inhibition by MnTBap suggest production of superoxide anion
during H and H/R.
It has been reported that an increase in myocardial NO produc-
tion occurs during hypoxia/reperfusion. To test this hypothesis in
cardiomyoblasts, dNO generation during H and H/R was measured
by quantitative oxidation of DAF-2-DA (a ﬂuorescent probe oxidized
by dNO) and inhibition by the NOS inhibitor L-NAME. As illustrated
in Fig. 3D and F, there is a high level of basal oxidation of DAF-2
which is not inhibitable by L-NAME and is indicative of NOS-
independent oxidation of the probe. Nevertheless, H/R signiﬁcantly
increased DAF ﬂuorescence compared to normoxia (Fig. 3D;
Po0.001) and this increase was prevented by the presence of
L-NAME. In cells maintained in H, the increase in DAF ﬂuorescence
was also signiﬁcant compared to normoxia (128.378.1% of nor-
moxic control, Po0.01) and again could be prevented by the
presence of L-NAME. These ﬁndings of DAF-2 oxidation inhibition
by L-NAME implicate NOS formation during H and H/R.
ROS and RNS mediate the cytotoxicity of hypoxia
To identify whether O2d, dNO and/or ONOO production are
implicated in H or H/R toxicity in cardiomyoblasts, the effects of 50 μM
MnTBap or 100 μM L-NAME on metabolic activity were analysed.
While MnTBap and L-NAME have no effect on the metabolic
activity of H9C2 cells under normoxic conditions, treatment of
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Fig. 2. Hypoxia and hypoxia/reoxygenation induces cell death and a decrease in metabolic activity but not protein concentration. H9C2 cells at 70–80% conﬂuence were
incubated in 2% 10% or 21% O2 equilibrated, HEPES-buffered, phenol red-free DMEM and exposed to (4 h) hypoxia. (A); The ratio of propidium iodide (PI)-positive stained
cells to total Hoechst stained cells was measured as an index of necrosis. ((B) and (C)); Procaspase 3 activation measured as cleavage relative to tubulin expression and
determined by western blotting. (D); Metabolic activity determined by MTT assay. (E); After 4 h hypoxia (2% O2), the medium was replaced with reoxygenated medium (2 h;
21% O2) for control and H/R experiments, and with hypoxic medium (2 h; 2% O2) for sustained hypoxia experiments and MTT activity was determined. Data represent the
mean 7S.E.M of three independent experiments conducted in triplicate. n represents Po0.05 and nn represents Po0.001 (one-way ANOVA) compared to controls, Tukey′s
post-hoc test.
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hypoxic cells with MnTBap during the reoxygenation period and in
sustained H afforded protection against toxicity (Fig. 4A–C). In
contrast, cytotoxicity was greater after inhibition of NOS with L-
NAME during H/R with 50% activity compared to cells treated
with L-NAME in normoxia (Po0.05; Fig. 4B) however, L-NAME
offered some protection (12%; Po0.05) for cells maintained
under S-H (Po0.001; Fig. 4C).
These data suggest that O2d production contributes in part to
the toxicity during both H and reoxygenation. In contrast to their
toxicity in S-H, dNO and/or related RNS are protective during
reoxygenation. This suggests a complex picture of NOS/ O2d-
dependent survival mechanisms and death pathways which co-
exist and where the nature and sites of reactive species production
may be key factors in determining toxicity.
ROS and RNS mediate Nrf2 activation during hypoxia/reoxygenation (H/R)
A marked increase in the activation of Nrf2 during ischaemia-
reperfusion has been reported in several cell types [17,23]. To
conﬁrm the activation of Nrf2 in H9C2 cells during H or H/R, cells
at 90–95% conﬂuence were co-transfected with pGL 3 [nqo1/luc]
plasmid with the NQO1 promoter / pGL 4.4 [TK/hRluc] control
plasmid for 24 h then incubated under normoxia, H/R or S-H for 6 h.
The efﬁciency of knockdown is shown in supplementary ﬁgure 1.
In the luciferase reporter assay, activated Nrf2 binds with ARE
region in NQO1-promoter to induce luciferase transcription/trans-
lation. Therefore, luciferase enzyme production and activity is
proportional to Nrf2 activation. Nrf2 was signiﬁcantly activated
during S-H and H/R in H2C9 cells (Fig. 5A; po0.01, and po0.001,
respectively).
To investigate if ROS and RNS produced during H and H/R were
mediating Nrf2 activation, cells were cultured under different
oxygen tensions in the presence of MnTBap or L-NAME. Inhibitors
had no signiﬁcant effect on Nrf2 activation under normoxic
conditions (Fig. 5B). MnTBap reduced signiﬁcantly the ARE-
mediated luciferase gene expression in H/R and S-H, suggesting
that O2d is important in the activation of Nrf2 gene transcription
under both conditions (Fig. 5C and Fig. 5D, respectively).
L-NAME also reduced ARE/NQO1 mediated luciferase gene
expression during H/R and during S-H, (Fig. 5C and D).
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Fig. 3. Effects of MnTBap and L-NAME on DHE and DAF2 oxidation during hypoxia/reperfusion. H9C2 cells at 70–80% conﬂuence were incubated in hypoxic medium
(2%O2; 4 h) or normoxic medium (21%O2; 4 h). After 4 h, culture medium was replaced with reoxygenated medium (21%O2; 2 h), for H/R and normoxia controls) or hypoxic
medium (2%O2; 2 h) in the presence and absence of 50 mM MnTBap or 100 mM L-NAME. Prior to analysis (t-45 min), cells were treated with 20 mM DHE ((A)–(C)) or 100 mM
DAF2-AM ((D)–(F)) and further incubated for 45 min to 6 h. The ﬂuorescence was measured at 37 1C in a Spectramax GEMINI EM ﬂuorescence reader at Ex: 488 nm,
Em; 570 nm for DHE; and Ex: 480–490 nm and Em: 510–520 nm for DAF2. Fluorescent images of normoxia ((B) and (E)) and H/R ((C) and (F)) were captured using Zeiss
700 LCM confocal microscope. Data represent the mean7SEM ﬂuorescence of three independent experiments conducted in triplicates. n represents Po0.05 or nn for
Po0.01 or nnn for Po0.001 (one-way ANOVA) compared to controls andþdenotes inhibitor signiﬁcance relative to non-inhibitor treated cells at the same oxygen tension
using Tukey′s post-hoc test.
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Nrf2 activation supports cell survival during hypoxia and hypoxia/
reoxygenation
Further investigation of the role for Nrf2 during H and H/R in
cardiomyoblasts was undertaken following Nrf2 knockdown (KD).
siRNA-treated Nrf2 cells exhibited a signiﬁcant decrease (440%)
in metabolic activity during H/R and S-H in comparison to non-
transfected controls and cells that had been transfected with
scrambled si-RNA implying an important role for Nrf2 in survival
during H and H/R (Fig. 6A). Nrf2-KD cells grown under normoxia
showed little cytotoxicity after knockdown beyond 6 h (data not
shown). Analysis of cellular glutathione conﬁrmed a signiﬁcant
loss of glutathione from cells during H with or without reoxygena-
tion which was not exacerbated by Nrf2 knockdown (Fig. 6B).
These data show that Nrf2 activation, in S-H and to a greater extent
by H/R, is associated with less cytotoxicity than when Nrf2 expression
is knocked down but that the protective effects of Nrf2 appear to be
independent of glutathione salvage after S-H or H/R. In S-H and H/R,
ROS and RNS appear to play a signiﬁcant role in Nrf2 induction.
In both environments, loss of Nrf2 impacted on cell survival but
the effect of Nrf2 loss in S-H was the greatest. This suggests that
other regulatory systems may be involved in the activation of Nrf2 or
be activated independently of Nrf2 during H/R and that nitric oxide/
RNS may be Involved in an alternative pathway of cytoprotection.
Discussion
Previously, we have shown that mitochondrial superoxide
anion radicals mediate toxicity during H in cardiomyoblasts [28].
Here we have extended our studies to demonstrate that NOS
activity also plays an important role in cytoprotection, particularly
during reoxygenation. ROS/RNS are also important mediators of
adaptive responses to stress, through reversibly modifying the
redox state of cysteine residues in KEAP-1 [13]. When cysteines in
KEAP-1 are reduced, KEAP1 binds to and negatively regulates Nrf2
by enhancing its rate of proteasomal degradation and altering its
subcellular distribution. However, once KEAP-1 is oxidised, Nrf2 is
stabilised and promotes induction of antioxidant gene expression
[14]. The observation that the mole rat, which burrows deep and
survives in hypoxic conditions, has constitutively activated Nrf2
supports the thesis that Nrf2 is a key regulator of survival during H
[33]. Our data using L-NAME as an inhibitor of NOS, suggest that in
addition to superoxide anion radical production, NOS activity is an
important contributor to the transactivation activity of Nrf2 which
in turn supports cardiomyoblast survival during H andH/R. Indeed,
partial Nrf2 knockdown increases cytotoxicity of H and H/R.
Nrf2-mediated antioxidant gene expression affords a highly speciﬁc
and co-ordinated response to protect the cells against H or
H/R-induced oxidative stress through induced expression of anti-
oxidant genes; e.g. NQO1, MnSOD and the glutathione transferase
(GST) pathway [19,34]. Here, MnTBap was able to inhibit Nrf2
activation during hypoxia and reoxygenation but as it can scavenge
both peroxynitrite and O2d [35] it is not possible to deduce from our
present study which speciﬁc oxygen and nitrogen radical species
mediate the Nrf2 activation and protective effects during H/R. Never-
theless, the protective effect of adding MnTBap but not L-NAME
during the reoxygenation phase despite its capacity to prevent Nrf-2
activation highlights an additional important protective effect of
scavenging O2d during reoxygenation.
In support of a role for peroxynitrite in Nrf2 activation during
H/R, Kang et al. [36] showed that during sulphur depletion,
peroxynitrite plays an essential role in nuclear translocation of
Nrf2 and ARE activation in rat hepatoma cells through the PI3-
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Fig. 4. MnTBap and L-NAME differentially inﬂuence the toxicity of hypoxia and hypoxia/reoxygenation in rat cardiomyoblasts. H9C2 cells were exposed to hypoxia (2%O2; 4 h) or
normoxic medium (21%O2; 4 h). After 4 h, culture mediumwas replaced with reoxygenated medium (21%O2 2 h) for H/R (B) and normoxia controls (A), or hypoxic medium (2%
O2; 2 h) (C) in the presence and absence of 50 mMMnTBap or 100 mM L-NAME and then further incubated for 2 h in the presence of MTT reagent. Data represents the mean7S.E.
M of three independent experiments conducted in triplicate. nnn represents Po0.001 and nn for Po0.01, n represents Po0.05 (one-way ANOVA), with Tukey′s post-hoc test.
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kinase pathway and that nitric oxide synthase is involved. Simi-
larly, Li showed that peroxynitrite activates Nrf2 via PI3K/Akt
signalling, enhances Nrf2-ARE binding, upregulates HO-1 expres-
sion and may confer an adaptive survival response against nitro-
sative stress in PC12 cells [37]. More recently, in HUVEC Mattart
et al. showed that sublethal peroxynitrite concentrations could
exert protective effects by modulating the balance between
autophagy and apoptosis through Nrf2-dependent pathways [38].
The inhibition of NOS and the scavenging of NO have been
described previously by Kawahara et al. to result in a signiﬁcant
decrease in the survival rate of myocytes during 3 h ischaemia
[39]. dNO served to balance ATP supply and demand during
ischemia, and during ischemia/reperfusion [39]. A recent study
in isolated ischemic cardiomyocytes, reported that the heat shock
protein Hsp22 enhanced NFκB and STAT-dependent iNOS expres-
sion and reduced H2O2-mediated apoptosis by 60%; this effect was
abolished by NOS inhibitors illustrating that NOS activation is an
alternative approach for preemptive treatment of myocardial
ischemia [40]. The difference in survival outcome that we
observed here following L-NAME treatment of cardiomyoblasts
during hypoxia (i.e. L-NAME protects) compared with H/R (i.e.
L-NAME exacerbates) may be due to differential local concentrations
of dNO and O2d [41]. In addition, the activation of an alternative
cytotoxic pathway during hypoxia and protective pathway during
reoxygenation may also be important.
L-NAME exacerbated toxicity during reoxygenation, conﬁrming
the absolute requirement for NO production to achieve cytopro-
tection. In contrast the decrease in cytotoxicity in the presence of
MnTBap despite a reduction in Nrf-2 suggests that the toxic effects
of O2d outweigh their beneﬁcial effects through activation of
adaptive pathways. It is likely that ROS/RNS may activate other
cytoprotective transcription factor pathways, such as those driven
by HIF-1 alpha [42].
Cellular redox imbalance is prevalent and complex in H and
H/R; this may explain the limited success of redox-modulating
interventions to improve outcome in H and H/R. Therapeutic use
of dNO donors such as nitrosoprusside may offer beneﬁts for
cardioprotection through supporting the adaptive response to
hypoxia and reoxygenation, in addition to their well- established
beneﬁts in vascular smooth muscle relaxation.
Conclusions
NOS activity is essential for the adaptation of cardiomyoblasts
to H/R via Nrf2-dependent effects, however, during hypoxia O2d
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Fig. 5. Hypoxia and hypoxia/reoxygenation increase Nrf2 activity in H9C2 cells in a superoxide and nitric oxide dependent manner. H9C2 cells grown to 90–95% conﬂuence
were transfected pGL3[nqo1/luc]/pGL 4.4 [hRluc/TK] plasmids (1.2 mg/ml): Lipofectamine 2000 complexes at 1:4 ratio for Nrf2 expression and cells were then incubated for
further 24 h. Cells were then incubated under 2% oxygen with and without re-oxygenation or 21% oxygen (normoxia) over 6 h; 100 mM H2O2 was used as a positive control
for Nrf2 activation after 4 h at 37 1C. Nrf2 activation was measured as the ratio of ﬁreﬂy to renila luciferase luminescence (A). The effects of MnTBap and L-NAME were
investigated on Nrf2 activation in normoxia (B), H/R (C) and sustained hypoxia (D). Data represent the mean7S.E.M of three independent experiments conducted in
triplicate. n represents Po0.05 (one-way ANOVA), Tukey′s post-hoc test.
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with NO appears to contribute to toxicity which is further
exacerbated in the absence of Nrf2.
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